Premenstrual syndrome and use of psychoactive substances
- Conditions
- PMDPremenstrual DisordersPMS Premenstrual syndromePMDD Premenstrual dysphoric disordersSubstance related disorders
- Registration Number
- NL-OMON21106
- Lead Sponsor
- ovadic-Kentron in association with UMC Radboud
- Brief Summary
Qurishi R, Sonneborn C, de Jong-Arts M, de Jong CAJ. Premenstrual syndrome and self-medication with opioids. J Addict Med. 2013 Jan-Feb;7(1):79-82. doi: 10.1097/ADM.0b013e31827884a3. <br> Qurishi R, Arts-de Jong M, Franzek EJ, Hartman L and De Jong CAJ. Influence of Premenstrual Syndrome on Relapse in Nicotine Abuse a Case Report . Austin J Drug Abuse and Addict. 2015; 2(1): 1005.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Inclusion criteria :
•Women between the ages of 18 and 45
Exclusion Criteria
Recent history of clinically significant psychiatric illness including any psychotic disorder e.g. schizophrenia, bipolar disorder or severe depression, suicidal ideation, menopause.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method association between level of PMS signs and symptoms and level of problematic use of psychoactive substances
- Secondary Outcome Measures
Name Time Method craving for psychoactive substances in relation to PMS sign and symptoms